NDC 71335-2974 – Ondansetron

Ondansetron 8 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC71335-2974

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA209389
Marketed since
June 19, 2025
Listing expires
December 31, 2027
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (10)

Package NDCDescriptionSince
71335-2974-014 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2974-0)Jan 12, 2026
71335-2974-130 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2974-1)Feb 12, 2026
71335-2974-210 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2974-2)Jan 5, 2026
71335-2974-39 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2974-3)Apr 16, 2026
71335-2974-45 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2974-4)Mar 20, 2026
71335-2974-53 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2974-5)Apr 16, 2026
71335-2974-66 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2974-6)Jan 12, 2026
71335-2974-712 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2974-7)Feb 6, 2026
71335-2974-84 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2974-8)Dec 30, 2025
71335-2974-920 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2974-9)Apr 6, 2026

Other Ondansetron products